CCXI stock forecast, quote, news & analysis
Churchill Capital Corp XI is a blank check company... Show more
Why Churchill Capital Corp XI (CCXI) Stock Is Down -26% in the Last 30 Days
Key Takeaways
- Churchill Capital Corp XI (CCXI) fell roughly 26% over the last 30 days, declining from a closing price of $11.62 on September 30 to an intraday level around $8.63.
- The stock is trading below its $10.00 initial public offering reference price, reflecting weak sentiment in the blank-check/SPAC segment.
- CCXI is a special purpose acquisition company with no significant operations, so its valuation is driven by expectations around a future merger rather than earnings.
- The decline followed a speculative run-up earlier in the quarter, when shares briefly climbed above $18 intraday before reversing lower.
- With no announced business combination, the shares have been sensitive to broader risk appetite and SPAC-sector sentiment.
- Explore additional Price Targets, Earnings, and Forecast data on Tickeron's dedicated CCXI pages for deeper analysis.
- Discover how automated strategies are approaching this and other tickers by exploring Trending AI Robots.
Churchill Capital Corp XI (CCXI) Company Overview and Market Position
Churchill Capital Corp XI is a special purpose acquisition company, commonly referred to as a SPAC or blank-check company. Incorporated in 2025 and based in New York, the company does not have significant operations. Its stated purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company is led by founder, chairman, and chief executive officer Michael Klein, a veteran dealmaker and sponsor of a series of Churchill Capital vehicles. CCXI completed its initial public offering in December 2025 and trades on the Nasdaq. Investors follow the stock primarily to gain exposure to a potential future acquisition, and its price reflects expectations about a deal rather than current revenue or profit fundamentals.
Churchill Capital Corp XI (CCXI) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, CCXI declined approximately 26%, moving from a closing price of $11.62 on September 30 to an intraday level around $8.63. The move extended a longer slide and pushed the shares below their $10.00 IPO reference price.
Looking at the last quarter, the stock's performance has been more volatile and ultimately more negative. In late July, CCXI traded near $14, and the shares rallied into mid-August, reaching an intraday high around $18.48 before reversing. From roughly $14 at the start of the period to the current level near $8.63, the stock has lost about 38% over the quarter, with the decline accelerating in October as the shares broke below $10.
What Drove CCXI Stock Price in the Last 30 Days
The 30-day decline in CCXI reflects a combination of speculative unwinding and broader weakness in the SPAC sector. With no announced merger target and no operating earnings to anchor its valuation, the stock trades largely on sentiment and the perceived likelihood of a future business combination. After a sharp rally in August, momentum faded, and shares entered a sustained downtrend. In October, the stock broke decisively below the $10.00 IPO level, a move that often signals reduced confidence among SPAC investors about a transaction completing on favorable terms. Risk-off conditions in the broader market and profit-taking following the earlier run-up added to the pressure. Without a specific catalyst, the decline has been driven primarily by the absence of deal news and shifting investor sentiment.
What Drove CCXI Stock Performance Over the Last Quarter
Across the quarter, CCXI's price action has been shaped by the typical dynamics of a pre-deal SPAC. The shares spiked in early-to-mid August as speculative demand pushed the stock above $18 intraday, but that enthusiasm faded quickly. With the company yet to announce a definitive merger agreement, there was no fundamental event to sustain the higher valuation, and the stock gradually gave back its gains. The steady deterioration into the low teens and then below $10 reflects a cooling of SPAC sentiment and a re-rating of the probability that a deal will be completed. The quarter's overall narrative is one of a speculative peak followed by a prolonged normalization toward, and ultimately below, the trust reference level.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of automated trading strategies from a platform that offers hundreds of AI-driven bots across thousands of tickers. Only top-performing and most relevant bots appear in this section, giving traders a focused view of strategies that are currently standing out. These bots vary widely in approach, holding timeframe, and performance metrics, so investors can compare different styles before committing. For those tracking tickers like CCXI, the page offers a way to observe how quantitative, rules-based systems are positioning in real time. Explore the Trending AI Robots section to see which automated strategies are drawing attention now.
CCXI Stock Forecast Drivers: What Investors Should Watch Next
The most important factor for CCXI is whether the company announces a business combination and on what terms. A definitive merger agreement would likely be the single most significant catalyst for the stock. Investors should also monitor the broader SPAC market, redemption rates, and overall risk appetite, as these influence how blank-check companies trade. Regulatory developments affecting SPACs and any updates from management about the timeline or target sector for a potential deal will be closely watched. Macroeconomic conditions, including interest rates and equity market volatility, also matter because they shape the financing environment for de-SPAC transactions. These factors should be monitored as factual drivers rather than as a basis for predictions or investment decisions.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CCXI in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 30, 2026
CCXI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 9 of 9 cases where CCXI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CCXI's RSI Oscillator exited the oversold zone, 8 of 10 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on CCXI as a result. In 15 of 24 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for CCXI just turned positive on November 03, 2026. Looking at past instances where CCXI's MACD turned positive, the stock continued to rise in 6 of 8 cases over the following month. The odds of a continued upward trend are 75%.
Following a +21.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCXI advanced for three days, in 51 of 78 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCXI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for CCXI entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. CCXI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.338) is normal, around the industry mean (-543.087). P/E Ratio (-5.958) is within average values for comparable stocks, (118.532). Projected Growth (PEG Ratio) (2.600) is also within normal values, averaging (15.932). Dividend Yield (0.000) settles around the average of (0.020) among similar stocks. CCXI's P/S Ratio (0.000) is very low in comparison to the industry average of (3.158).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CCXI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer and commercializer of small molecule therapeutics
Industry FinancialConglomerates